Analysis of RNA polymerase by trypsin cleavage. Different structural changes produced by heparin and DNA.
Alterations in RNA polymerase structure can be detected using initial trypsin cleavage rates as a conformational probe. Both template (poly[d(A-T) . d(A-T)] and the RNA polymerase inhibitor, heparin, alter the rates at which the subunits of the enzyme are cleaved. However, while the presence of poly[d(A-T) . d(A-T)] slows the cleavage of subunits beta, sigma, and alpha by trypsin, heparin accelerates the cleavage of beta and sigma. Furthermore, the presence of heparin does not prevent the effect of poly[d(A-T) . d(A-T)] on the beta and sigma cleavage rates. Thus, heparin does not eliminate the interaction between DNA and RNA polymerase. That heparin does alter the nature of this interaction is demonstrated by the fact that template decreases the trypsin cleavage rate of subunit alpha in the absence, but not in the presence, of heparin. Like heparin, the addition of RNA to the reaction increases the accessibility of beta and sigma to trypsin. Hence the interaction of heparin with RNA polymerase may mimic the product, rather than the template, interaction.
D012321:DNA-Directed RNA Polymerases / Q000378:metabolism*; D004926:Escherichia coli / Q000201:enzymology; D006493:Heparin / Q000494:pharmacology*; D010446:Peptide Fragments / Q000032:analysis; D011067:Poly dA-dT / Q000494:pharmacology*; D011089:Polydeoxyribonucleotides / Q000494:pharmacology*; D014357:Trypsin / Q000378:metabolism*
D010446:Peptide Fragments; D011089:Polydeoxyribonucleotides; D011067:Poly dA-dT; D006493:Heparin; D012321:DNA-Directed RNA Polymerases; D014357:Trypsin